Skip to main content
Top
Published in: European Journal of Trauma and Emergency Surgery 5/2023

09-06-2023 | Care | Original Article

Gut barrier protein levels in serial blood samples from critically ill trauma patients during and after intensive care unit stay

Authors: Hamiyet Donmez-Altuntas, Serap Sahin Ergul, Pinar Altin-Celik, Kadir Bulut, Hamiyet Eci̇roglu, Ramazan Uzen, Gulsah Gunes Sahin, Nurhayat Tugra Ozer, Sahin Temel, Turkmen Bahadir Arikan, Aliye Esmaoglu, Recep Civan Yuksel, Murat Sungur, Kursat Gundogan

Published in: European Journal of Trauma and Emergency Surgery | Issue 5/2023

Login to get access

Abstract

Purpose

In an effort to better manage critically ill patients hospitalised in the intensive care unit (ICU) after experiencing multiple traumas, the present study aimed to assess whether plasma levels of intestinal epithelial cell barrier proteins, including occludin, claudin-1, junctional adhesion molecule (JAM-1), tricellulin and zonulin, could be used as novel biomarkers. Additional potential markers such as intestinal fatty acid-binding protein (I-FABP), d-lactate, lipopolysaccharide (LPS) and citrulline were also evaluated. We also aimed to determine the possible relationships between the clinical, laboratory, and nutritional status of patients and the measured marker levels.

Methods

Plasma samples from 29 patients (first, second, fifth and tenth days in the ICU and on days 7, 30 and 60 after hospital discharge) and 23 controls were subjected to commercial enzyme-linked immunosorbent assay (ELISA) testing.

Results

On first day (admission) and on the second day, plasma I-FABP, d-lactate, citrulline, occludin, claudin-1, tricellulin and zonulin levels were high in trauma patients and positively correlated with lactate, C-reactive protein (CRP), number of days of ICU hospitalisation, Acute Physiology and Chronic Health Evaluation II (APACHE II) score and daily Sequential Organ Failure Assessment (SOFA) scores (P < 0.05–P < 0.01).

Conclusion

The results of the present study showed that occludin, claudin-1, tricellulin and zonulin proteins, as well as I-FABP, d-lactate and citrulline, may be used as promising biomarkers for the evaluation of disease severity in critically ill trauma patients, despite the complexity of the analysis of various barrier markers. However, our results should be supported by future studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Puleo F, Arvanitakis M, Van Gossum A, Preiser J-C. Gut failure in the ICU. Semin Respir Crit Care Med. 2011;32(5):626–38.PubMedCrossRef Puleo F, Arvanitakis M, Van Gossum A, Preiser J-C. Gut failure in the ICU. Semin Respir Crit Care Med. 2011;32(5):626–38.PubMedCrossRef
2.
go back to reference Ackland G, Grocott MP, Mythen MG. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care. 2000;4(5):1–13.CrossRef Ackland G, Grocott MP, Mythen MG. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care. 2000;4(5):1–13.CrossRef
3.
go back to reference Denk S, Wiegner R, Hönes FM, Messerer DA, Radermacher P, Weiss M, Kalbitz M, Ehrnthaller C, Braumüller S, McCook O. Early detection of junctional adhesion molecule-1 (JAM-1) in the circulation after experimental and clinical polytrauma. Mediators Inflamm. 2015;2015:1–7.CrossRef Denk S, Wiegner R, Hönes FM, Messerer DA, Radermacher P, Weiss M, Kalbitz M, Ehrnthaller C, Braumüller S, McCook O. Early detection of junctional adhesion molecule-1 (JAM-1) in the circulation after experimental and clinical polytrauma. Mediators Inflamm. 2015;2015:1–7.CrossRef
4.
go back to reference Reintam Blaser A, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU. Curr Opin Crit Care. 2016;22(2):128–41.PubMed Reintam Blaser A, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU. Curr Opin Crit Care. 2016;22(2):128–41.PubMed
5.
go back to reference Li H, Chen Y, Huo F, Wang Y, Zhang D. Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients. BMC Gastroenterol. 2017;17:1–8.CrossRef Li H, Chen Y, Huo F, Wang Y, Zhang D. Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients. BMC Gastroenterol. 2017;17:1–8.CrossRef
6.
go back to reference Asrani VM, Brown A, Huang W, Bissett I, Windsor JA. Gastrointestinal dysfunction in critical illness: a review of scoring tools. J Parenter Enter Nutr. 2020;44(2):182–96.CrossRef Asrani VM, Brown A, Huang W, Bissett I, Windsor JA. Gastrointestinal dysfunction in critical illness: a review of scoring tools. J Parenter Enter Nutr. 2020;44(2):182–96.CrossRef
7.
go back to reference Reintam Blaser A, Preiser J-C, Fruhwald S, Wilmer A, Wernerman J, Benstoem C, Casaer MP, Starkopf J, van Zanten A, Rooyackers O. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020;24:1–17.CrossRef Reintam Blaser A, Preiser J-C, Fruhwald S, Wilmer A, Wernerman J, Benstoem C, Casaer MP, Starkopf J, van Zanten A, Rooyackers O. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020;24:1–17.CrossRef
8.
go back to reference Zhang X, Wang L, Chen D-C. Effect of rhubarb on gastrointestinal dysfunction in critically III patients: a retrospective study based on propensity score matching. Chin Med J. 2018;131(10):1142–50.PubMedPubMedCentralCrossRef Zhang X, Wang L, Chen D-C. Effect of rhubarb on gastrointestinal dysfunction in critically III patients: a retrospective study based on propensity score matching. Chin Med J. 2018;131(10):1142–50.PubMedPubMedCentralCrossRef
9.
go back to reference Blaser A, Padar M, Tang J, Dutton J, Forbes A. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill. Anaesthesiol Intensive Ther. 2019;51(3):230–9.PubMedCrossRef Blaser A, Padar M, Tang J, Dutton J, Forbes A. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill. Anaesthesiol Intensive Ther. 2019;51(3):230–9.PubMedCrossRef
10.
go back to reference Ewaschuk JB, Naylor JM, Zello GA. d-lactate in human and ruminant metabolism. J Nutr. 2005;135(7):1619–25.PubMedCrossRef Ewaschuk JB, Naylor JM, Zello GA. d-lactate in human and ruminant metabolism. J Nutr. 2005;135(7):1619–25.PubMedCrossRef
11.
go back to reference Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. United Eur Gastroenterol J. 2018;6(2):181–91.CrossRef Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. United Eur Gastroenterol J. 2018;6(2):181–91.CrossRef
12.
go back to reference Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocrine Soc. 2020;4(2):bvz039.CrossRef Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocrine Soc. 2020;4(2):bvz039.CrossRef
13.
go back to reference Monroe GR, van Eerde AM, Tessadori F, Duran KJ, Savelberg SM, van Alfen JC, Terhal PA, van der Crabben SN, Lichtenbelt KD, Fuchs SA. Identification of human D lactate dehydrogenase deficiency. Nat Commun. 2019;10(1):1477.PubMedPubMedCentralCrossRef Monroe GR, van Eerde AM, Tessadori F, Duran KJ, Savelberg SM, van Alfen JC, Terhal PA, van der Crabben SN, Lichtenbelt KD, Fuchs SA. Identification of human D lactate dehydrogenase deficiency. Nat Commun. 2019;10(1):1477.PubMedPubMedCentralCrossRef
14.
go back to reference Moonen P-J, Blaser A, Starkopf J, Oudemans-van Straaten H, Van der Mullen J, Vermeulen G, Malbrain M. The black box revelation: monitoring gastrointestinal function. Anestezjol Intens Ter. 2019;50(1):73–82. Moonen P-J, Blaser A, Starkopf J, Oudemans-van Straaten H, Van der Mullen J, Vermeulen G, Malbrain M. The black box revelation: monitoring gastrointestinal function. Anestezjol Intens Ter. 2019;50(1):73–82.
15.
go back to reference Peoc’h K, Nuzzo A, Guedj K, Paugam C, Corcos O. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. Clin Chem Lab Med (CCLM). 2018;56(3):373–85.PubMedCrossRef Peoc’h K, Nuzzo A, Guedj K, Paugam C, Corcos O. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. Clin Chem Lab Med (CCLM). 2018;56(3):373–85.PubMedCrossRef
16.
go back to reference Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011;37:911–7.PubMedCrossRef Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011;37:911–7.PubMedCrossRef
17.
go back to reference Pohanka M. d-lactic acid as a metabolite: toxicology, diagnosis, and detection. BioMed Res Int. 2020;2020:1–9.CrossRef Pohanka M. d-lactic acid as a metabolite: toxicology, diagnosis, and detection. BioMed Res Int. 2020;2020:1–9.CrossRef
18.
go back to reference Shi H, Wu B, Wan J, Liu W, Su B. The role of serum intestinal fatty acid binding protein levels and d-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol. 2015;39(3):373–8.PubMedCrossRef Shi H, Wu B, Wan J, Liu W, Su B. The role of serum intestinal fatty acid binding protein levels and d-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol. 2015;39(3):373–8.PubMedCrossRef
19.
go back to reference Voth M, Duchene M, Auner B, Lustenberger T, Relja B, Marzi I. I-FABP is a novel marker for the detection of intestinal injury in severely injured trauma patients. World J Surg. 2017;41:3120–7.PubMedCrossRef Voth M, Duchene M, Auner B, Lustenberger T, Relja B, Marzi I. I-FABP is a novel marker for the detection of intestinal injury in severely injured trauma patients. World J Surg. 2017;41:3120–7.PubMedCrossRef
20.
go back to reference Garcia-Hernandez V, Quiros M, Nusrat A. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann N Y Acad Sci. 2017;1397(1):66–79.PubMedPubMedCentralCrossRef Garcia-Hernandez V, Quiros M, Nusrat A. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann N Y Acad Sci. 2017;1397(1):66–79.PubMedPubMedCentralCrossRef
21.
23.
go back to reference Lee B, Moon KM, Kim CY. Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals. J Immunol Res. 2018;2018:1–11.CrossRef Lee B, Moon KM, Kim CY. Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals. J Immunol Res. 2018;2018:1–11.CrossRef
24.
go back to reference Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113(24):4435–40.PubMedCrossRef Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113(24):4435–40.PubMedCrossRef
25.
go back to reference Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut. 2019;68(3):547–61.PubMedCrossRef Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut. 2019;68(3):547–61.PubMedCrossRef
26.
go back to reference Halbgebauer R, Braun CK, Denk S, Mayer B, Cinelli P, Radermacher P, Wanner GA, Simmen H-P, Gebhard F, Rittirsch D. Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytrauma. J Crit Care. 2018;44:229–37.PubMedCrossRef Halbgebauer R, Braun CK, Denk S, Mayer B, Cinelli P, Radermacher P, Wanner GA, Simmen H-P, Gebhard F, Rittirsch D. Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytrauma. J Crit Care. 2018;44:229–37.PubMedCrossRef
27.
go back to reference McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211.PubMedCrossRef McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211.PubMedCrossRef
28.
go back to reference Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79.PubMedCrossRef Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79.PubMedCrossRef
29.
go back to reference van Zanten ARH, De Waele E, Wischmeyer PE. Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases. Crit Care. 2019;23(1):1–10. van Zanten ARH, De Waele E, Wischmeyer PE. Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases. Crit Care. 2019;23(1):1–10.
30.
go back to reference Osuka A, Kusuki H, Matsuura H, Shimizu K, Ogura H, Ueyama M. Acute intestinal damage following severe burn correlates with the development of multiple organ dysfunction syndrome: a prospective cohort study. Burns J Int Soc Burn Injuries. 2017;43(4):824–9.CrossRef Osuka A, Kusuki H, Matsuura H, Shimizu K, Ogura H, Ueyama M. Acute intestinal damage following severe burn correlates with the development of multiple organ dysfunction syndrome: a prospective cohort study. Burns J Int Soc Burn Injuries. 2017;43(4):824–9.CrossRef
31.
go back to reference Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87(2):545–64.PubMedCrossRef Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87(2):545–64.PubMedCrossRef
32.
33.
go back to reference Kuo WT, Shen L, Zuo L, Shashikanth N, Ong M, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, Nilsen SP, Turner JR. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157(5):1323–37.PubMedCrossRef Kuo WT, Shen L, Zuo L, Shashikanth N, Ong M, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, Nilsen SP, Turner JR. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157(5):1323–37.PubMedCrossRef
34.
35.
go back to reference Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal cancer. Front Immunol. 2019;10:1441.PubMedPubMedCentralCrossRef Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal cancer. Front Immunol. 2019;10:1441.PubMedPubMedCentralCrossRef
36.
go back to reference Lameris AL, Huybers S, Kaukinen K, Mäkelä TH, Bindels RJ, Hoenderop JG, Nevalainen PI. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease. Scand J Gastroenterol. 2013;48(1):58–69.PubMedCrossRef Lameris AL, Huybers S, Kaukinen K, Mäkelä TH, Bindels RJ, Hoenderop JG, Nevalainen PI. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease. Scand J Gastroenterol. 2013;48(1):58–69.PubMedCrossRef
37.
go back to reference Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K. Predicted expansion of the claudin multigene family. FEBS Lett. 2011;585(4):606–12.PubMedCrossRef Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K. Predicted expansion of the claudin multigene family. FEBS Lett. 2011;585(4):606–12.PubMedCrossRef
38.
go back to reference Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88(10):1110–20.PubMedPubMedCentralCrossRef Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88(10):1110–20.PubMedPubMedCentralCrossRef
39.
go back to reference Cording J, Günther R, Vigolo E, Tscheik C, Winkler L, Schlattner I, Lorenz D, Haseloff RF, Schmidt-Ott KM, Wolburg H. Redox regulation of cell contacts by tricellulin and occludin: redox-sensitive cysteine sites in tricellulin regulate both tri-and bicellular junctions in tissue barriers as shown in hypoxia and ischemia. Antioxid Redox Signal. 2015;23(13):1035–49.PubMedCrossRef Cording J, Günther R, Vigolo E, Tscheik C, Winkler L, Schlattner I, Lorenz D, Haseloff RF, Schmidt-Ott KM, Wolburg H. Redox regulation of cell contacts by tricellulin and occludin: redox-sensitive cysteine sites in tricellulin regulate both tri-and bicellular junctions in tissue barriers as shown in hypoxia and ischemia. Antioxid Redox Signal. 2015;23(13):1035–49.PubMedCrossRef
40.
go back to reference Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol. 2005;171(6):939–45.PubMedPubMedCentralCrossRef Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol. 2005;171(6):939–45.PubMedPubMedCentralCrossRef
41.
go back to reference Krug S, Bojarski C, Fromm A, Lee I, Dames P, Richter J, Turner J, Fromm M, Schulzke J. Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11(2):345–56.PubMedCrossRef Krug S, Bojarski C, Fromm A, Lee I, Dames P, Richter J, Turner J, Fromm M, Schulzke J. Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11(2):345–56.PubMedCrossRef
43.
go back to reference Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518–9.PubMedCrossRef Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518–9.PubMedCrossRef
44.
go back to reference Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4): e1251384.PubMedPubMedCentralCrossRef Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4): e1251384.PubMedPubMedCentralCrossRef
45.
go back to reference Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci. 2009;106(39):16799–804.PubMedPubMedCentralCrossRef Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci. 2009;106(39):16799–804.PubMedPubMedCentralCrossRef
46.
go back to reference Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochem Med. 2013;23(1):107–11.CrossRef Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochem Med. 2013;23(1):107–11.CrossRef
47.
go back to reference Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE. 2012;7(5): e37160.PubMedPubMedCentralCrossRef Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE. 2012;7(5): e37160.PubMedPubMedCentralCrossRef
48.
go back to reference Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk Ł, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013;2013:1–9.CrossRef Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk Ł, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013;2013:1–9.CrossRef
49.
go back to reference Robinson BD, Tharakan B, Lomas A, Wiggins-Dohlvik K, Alluri H, Shaji CA. Jupiter D, Isbell CL (2020) Exploring blood–brain barrier hyperpermeability and potential biomarkers in traumatic brain injury. In: Baylor University Medical Center proceedings: 2020. Taylor & Francis, pp 199–204 Robinson BD, Tharakan B, Lomas A, Wiggins-Dohlvik K, Alluri H, Shaji CA. Jupiter D, Isbell CL (2020) Exploring blood–brain barrier hyperpermeability and potential biomarkers in traumatic brain injury. In: Baylor University Medical Center proceedings: 2020. Taylor & Francis, pp 199–204
50.
go back to reference Blaser AR, Padar M, Mändul M, Elke G, Engel C, Fischer K, Giabicani M, Gold T, Hess B, Hiesmayr M, Jakob SM, Loudet CI, Meesters DM, Mongkolpun W, Paugam-Burtz C, Poeze M, Preiser JC, Renberg M, Rooijackers O, Tamme K, Wernerman J, Starkopf J. Development of the gastrointestinal dysfunction score (GIDS) for critically ill patients—a prospective multicenter observational study (iSOFA study). Clin Nutr. 2021;40(8):4932–40.CrossRef Blaser AR, Padar M, Mändul M, Elke G, Engel C, Fischer K, Giabicani M, Gold T, Hess B, Hiesmayr M, Jakob SM, Loudet CI, Meesters DM, Mongkolpun W, Paugam-Burtz C, Poeze M, Preiser JC, Renberg M, Rooijackers O, Tamme K, Wernerman J, Starkopf J. Development of the gastrointestinal dysfunction score (GIDS) for critically ill patients—a prospective multicenter observational study (iSOFA study). Clin Nutr. 2021;40(8):4932–40.CrossRef
Metadata
Title
Gut barrier protein levels in serial blood samples from critically ill trauma patients during and after intensive care unit stay
Authors
Hamiyet Donmez-Altuntas
Serap Sahin Ergul
Pinar Altin-Celik
Kadir Bulut
Hamiyet Eci̇roglu
Ramazan Uzen
Gulsah Gunes Sahin
Nurhayat Tugra Ozer
Sahin Temel
Turkmen Bahadir Arikan
Aliye Esmaoglu
Recep Civan Yuksel
Murat Sungur
Kursat Gundogan
Publication date
09-06-2023
Publisher
Springer Berlin Heidelberg
Keyword
Care
Published in
European Journal of Trauma and Emergency Surgery / Issue 5/2023
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-023-02298-6

Other articles of this Issue 5/2023

European Journal of Trauma and Emergency Surgery 5/2023 Go to the issue